West Pharmaceutical Services (WST) Inventory (2009 - 2026)

West Pharmaceutical Services has disclosed Inventory across 18 years of filings, most recently posting $452.6 million for Q1 2026.

• Inventory for Q1 2026 came in at $452.6 million, up 16.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $452.6 million (up 16.44% YoY), and the FY2025 annual result was $443.9 million, up 17.75% from the prior year.
• Inventory came in at $452.6 million for Q1 2026 at West Pharmaceutical Services, up from $443.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $452.6 million in Q1 2026 to a low of $377.0 million in Q4 2024.
• The 5-year median for Inventory is $421.1 million (2025), against an average of $423.0 million.
• Across the five-year window, Inventory surged 34.27% in 2022 and fell 13.27% in 2024, its largest moves.
• West Pharmaceutical Services' Inventory stood at $414.8 million in 2022, then climbed by 4.8% to $434.7 million in 2023, then fell by 13.27% to $377.0 million in 2024, then rose by 17.75% to $443.9 million in 2025, then rose by 1.96% to $452.6 million in 2026.
• The last three Inventory figures came in at $452.6 million (Q1 2026), $443.9 million (Q4 2025), and $438.0 million (Q3 2025), per Business Quant data.